Lipocine Inc. Share Price
NASDAQ: LPCN | Micro CapLipocine Inc. Stock Performance
Lipocine Inc. Share Price Today
As of 29 October 2026, Lipocine Inc.'s share price is $1.52. The stock opened at $1.51, compared to its previous close of $1.53. During today's trading session, Lipocine Inc.'s share price traded between $1.51 and $1.51, with an average price of $1.51. Over the past 52 weeks, the stock has recorded a high of $12.35 and a low of $1.40. In terms of performance, Lipocine Inc.'s share price has declined by 35.11% over the last six months and is down 42.45% on a year-on-year basis.
Lipocine Inc. Share Price Chart
Lipocine Inc. Quarterly Profit & Loss
All figures in USD
Lipocine Inc. Annual Profit & Loss
All figures in USD
About Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates, or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy (TRT). It also has other products in the pipeline, such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
Lipocine Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $2.16 | $1.51 | -32.59% |
Sep 2026 | $2.36 | $2.24 | -0.44% |
Aug 2026 | $2.10 | $2.25 | +6.64% |
Jul 2026 | $2.46 | $2.11 | -18.53% |
Jun 2026 | $2.28 | $2.59 | +14.10% |
May 2026 | $2.38 | $2.27 | -3.40% |
Apr 2026 | $7.89 | $2.35 | -70.25% |
Mar 2026 | $9.35 | $7.90 | -20.68% |
Feb 2026 | $8.06 | $9.96 | +10.67% |
Jan 2026 | $8.02 | $9.00 | +10.02% |
Dec 2025 | $3.10 | $8.18 | +150.92% |
Nov 2025 | $2.66 | $3.26 | +23.02% |